Onyx (ONXX) volatility flat into Kyprolis FDA panel vote

Onyx Pharmaceutical (Nasdaq: ONXX) overall option implied volatility of 50 is near its 26-week average of 53 according to Track Data, suggesting non-directional price movement as shares are halted into a FDA panel vote for Kyprolis.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• PENN Entertainment (PENN) call put ratio 10 calls to 1 put with focus on April weekly 19.50 calls
• Teladoc (TDOC) call put ratio 1 call to 2.9 puts into quarter results
• Royal Caribbean (RCL) April weekly option implied volatility into quarter results